You are here: Home » News-CM » Companies » Results
Business Standard

Bliss GVS Pharma standalone net profit declines 20.31% in the September 2017 quarter

Capital Market 

Sales decline 19.00% to Rs 71.85 crore

Net profit of declined 20.31% to Rs 16.01 crore in the quarter ended September 2017 as against Rs 20.09 crore during the previous quarter ended September 2016. Sales declined 19.00% to Rs 71.85 crore in the quarter ended September 2017 as against Rs 88.70 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales71.8588.70 -19 OPM %29.5636.51 -PBDT25.4031.79 -20 PBT24.3630.34 -20 NP16.0120.09 -20

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Sat, December 02 2017. 12:50 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU